237 related articles for article (PubMed ID: 34480056)
1. Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients.
Moura AD; da Costa HHM; Correa VA; de S Lima AK; Lindoso JAL; De Gaspari E; Hong MA; Cunha-Junior JP; Prudencio CR
Sci Rep; 2021 Sep; 11(1):17642. PubMed ID: 34480056
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
3. Incomplete IgG avidity maturation after seasonal coronavirus infections.
Struck F; Schreiner P; Staschik E; Wochinz-Richter K; Schulz S; Soutschek E; Motz M; Bauer G
J Med Virol; 2022 Jan; 94(1):186-196. PubMed ID: 34427932
[TBL] [Abstract][Full Text] [Related]
4. Clinical and antibody characteristics reveal diverse signatures of severe and non-severe SARS-CoV-2 patients.
Wang H; Yan D; Li Y; Gong Y; Mai Y; Li B; Zhu X; Wan X; Xie L; Jiang H; Zhang M; Sun M; Yao Y; Zhu Y
Infect Dis Poverty; 2022 Feb; 11(1):15. PubMed ID: 35109926
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
Front Immunol; 2021; 12():767981. PubMed ID: 34804055
[TBL] [Abstract][Full Text] [Related]
7. Antibody response to SARS-CoV-2 for more than one year - kinetics and persistence of detection are predominantly determined by avidity progression and test design.
Scheiblauer H; Nübling CM; Wolf T; Khodamoradi Y; Bellinghausen C; Sonntagbauer M; Esser-Nobis K; Filomena A; Mahler V; Maier TJ; Stephan C
J Clin Virol; 2022 Jan; 146():105052. PubMed ID: 34920374
[TBL] [Abstract][Full Text] [Related]
8. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
9. An original multiplex method to assess five different SARS-CoV-2 antibodies.
Favresse J; Brauner J; Bodart N; Vigneron A; Roisin S; Melchionda S; Douxfils J; Ocmant A
Clin Chem Lab Med; 2021 Apr; 59(5):971-978. PubMed ID: 33554567
[TBL] [Abstract][Full Text] [Related]
10. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
[TBL] [Abstract][Full Text] [Related]
11. The Characterization of Disease Severity Associated IgG Subclasses Response in COVID-19 Patients.
Luo H; Jia T; Chen J; Zeng S; Qiu Z; Wu S; Li X; Lei Y; Wang X; Wu W; Zhang R; Zou X; Feng T; Ding R; Zhang Y; Chen YQ; Sun C; Wang T; Fang S; Shu Y
Front Immunol; 2021; 12():632814. PubMed ID: 33763078
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
13. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response.
Wu J; Liu X; Shao J; Zhang Y; Lu R; Xue H; Xu Y; Wang L; Zhou H; Yu L; Yue M; Dong C
Virol J; 2021 Dec; 18(1):244. PubMed ID: 34876159
[TBL] [Abstract][Full Text] [Related]
14. The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity.
Hajilooi M; Keramat F; Moazenian A; Rastegari-Pouyani M; Solgi G
Med Microbiol Immunol; 2023 Jun; 212(3):203-220. PubMed ID: 37103583
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Kinetics of Antibody Avidity and IgG Subclasses' Response in Patients with COVID-19 and Healthy Individuals Vaccinated with the BNT162B2 (Comirnaty, Pfizer/BioNTech) mRNA Vaccine.
Rastawicki W; Gierczyński R; Zasada AA
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112950
[TBL] [Abstract][Full Text] [Related]
16. Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity.
Korobova ZR; Zueva EV; Arsentieva NA; Batsunov OK; Liubimova NE; Khamitova IV; Kuznetsova RN; Rubinstein AA; Savin TV; Stanevich OV; Kulikov AN; Pevtsov DE; Totolian AA
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632683
[TBL] [Abstract][Full Text] [Related]
17. Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
Fujigaki H; Inaba M; Osawa M; Moriyama S; Takahashi Y; Suzuki T; Yamase K; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Doi Y; Saito K
J Immunol; 2021 May; 206(10):2393-2401. PubMed ID: 33941657
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19.
Wu J; Liang B; Chen C; Wang H; Fang Y; Shen S; Yang X; Wang B; Chen L; Chen Q; Wu Y; Liu J; Yang X; Li W; Zhu B; Zhou W; Wang H; Li S; Lu S; Liu D; Li H; Krawczyk A; Lu M; Yang D; Deng F; Dittmer U; Trilling M; Zheng X
Nat Commun; 2021 Mar; 12(1):1813. PubMed ID: 33753738
[TBL] [Abstract][Full Text] [Related]
19. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
Front Immunol; 2020; 11():609242. PubMed ID: 33424863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
